Skip to main content
. 2022 Nov 9;15:3483–3497. doi: 10.2147/DMSO.S387040

Figure 1.

Figure 1

Flow chart for inclusion of participants in this study.

Notes: A total of 1565 participants were recruited at baseline, and all patients were screened according to exclusion criteria. Of these, 216 participants were diagnosed with diabetes other than type 2 (including type 1 diabetes, gestational diabetes, secondary diabetes), 36 participants had organ insufficiency, and 19 participants had autoimmune disease or blood disease, 27 participants had malignancy, 58 had severe infection within the last three months, 2 had congenital heart disease, 364 had incomplete baseline data, and 75 had incomplete follow-up information. After excluding the above participants, a total of 858 subjects were included in the study.